U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312058) titled 'Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology' on Nov. 17, 2025.
Brief Summary: Cancer treatments, despite their increasing effectiveness, carry a significant risk of gametotoxicity.
Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment.
However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission.
This project aims to better understand the effectiveness, utilization, and psychological impacts of these ...